Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-09-11Phase I/II Trial of Weekly Motexafin Gadolinium (MGd) for Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
CLINICAL_TRIALS study record update · 2008-08-26Randomized Controlled Trial of Exercise in Lymphoma Patients
-
CLINICAL_TRIALS study record update · 2008-07-24An Open Phase II Multi-Center Trial of BAY 59-8862 in Patients With Aggressive Refractory Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2008-05-20A Multicenter, Open-Label, Phase I Study Evaluating the Safety and Tolerability of Intravenous Pegaspargase in Combination With Intravenous Gemcitabine HCl in the Treatment of Advanced and/or Metastatic Solid Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
-
CLINICAL_TRIALS study record update · 2008-03-04In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
-
CLINICAL_TRIALS study record update · 2008-03-04Phase I Study of Intrathecal Topotecan
-
CLINICAL_TRIALS study record update · 2008-03-04HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
-
CLINICAL_TRIALS study record update · 2008-03-04Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
-
CLINICAL_TRIALS study record update · 2008-03-04The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2008-03-04Evaluation and Natural History of Children With Cancer and AIDS
-
CLINICAL_TRIALS study record update · 2008-02-28Randomized, Double-Blind Study of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Pegfilgrastim or Filgrastim for Autologous Transplantation in Subjects With Hodgkin's or Non-Hodgkin's Lymphoma.
-
CLINICAL_TRIALS study record update · 2008-02-08Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning With Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched Family Donor Hematopoietic Cell Transplants
-
CLINICAL_TRIALS study record update · 2008-01-28VELCADE (Bortezomib) for Injection - Phase II Study of Bortezomib and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2007-12-28Pediatric Phase I Trial of BL22 for Refractory CD22-Positive Leukemias and Lymphomas
-
CLINICAL_TRIALS study record update · 2007-11-20Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
-
CLINICAL_TRIALS study record update · 2007-11-01Phase III Study of Treatment of Disseminated and Agressive Lymphoma R CHOP Versus R CLOP( With Liposomal Doxorubicin)
-
CLINICAL_TRIALS study record update · 2007-09-11Phase 1 Study of CS-1008, a Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5), Administered Weekly to Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)
-
CLINICAL_TRIALS study record update · 2007-08-17Phase 3 Study of Dose-Dense Therapy Versus CHOP in Aggressive Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2007-07-03FL-2000 Study for Newly Diagnosed Follicular Lymphoma Patients With a High Tumor Burden
-
CLINICAL_TRIALS study record update · 2007-06-14A Phase I Open-Label Dose Escalation Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
-
CLINICAL_TRIALS study record update · 2007-05-15Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma